Special Issue "Ocular Drug Delivery"

Quicklinks

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (30 December 2011)

Special Issue Editor

Guest Editor
Prof. Dr. Alon Harris
Director of Clinical Research, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, 702 Rotary Circle, Room 137, Indianapolis, IN 46202, USA
Website: http://iueye.iu.edu/faculty1/alon-harris-ph-d-farvo/
E-Mail: alharris@indiana.edu
Phone: +1 317 278 0177
Fax: +1 317 278 1007
Interests: glaucoma; diabetes; age-related macular degeneration; vascular; blood flow; ischemia; perfusion; treatments

Keywords

  • glaucoma
  • diabetes
  • age-related macular degeneration
  • vascular
  • blood flow
  • ischemia
  • perfusion
  • treatments

Published Papers (5 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-5
p. 252-275
by , ,  and
Pharmaceutics 2012, 4(2), 252-275; doi:10.3390/pharmaceutics4020252
Received: 8 February 2012; in revised form: 17 April 2012 / Accepted: 5 May 2012 / Published: 14 May 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (687 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
p. 243-251
by ,  and
Pharmaceutics 2012, 4(1), 243-251; doi:10.3390/pharmaceutics4010243
Received: 14 February 2012; in revised form: 29 February 2012 / Accepted: 14 March 2012 / Published: 21 March 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (96 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
p. 230-242
by , , , ,  and
Pharmaceutics 2012, 4(1), 230-242; doi:10.3390/pharmaceutics4010230
Received: 7 February 2012; in revised form: 28 February 2012 / Accepted: 9 March 2012 / Published: 15 March 2012
Show/Hide Abstract | PDF Full-text (227 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
abstract graphic
p. 212-229
by , , , , ,  and
Pharmaceutics 2012, 4(1), 212-229; doi:10.3390/pharmaceutics4010212
Received: 13 February 2012; in revised form: 29 February 2012 / Accepted: 29 February 2012 / Published: 12 March 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (3246 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
p. 197-211
by , , , , ,  and
Pharmaceutics 2012, 4(1), 197-211; doi:10.3390/pharmaceutics4010197
Received: 22 December 2011; in revised form: 6 February 2012 / Accepted: 1 March 2012 / Published: 8 March 2012
Show/Hide Abstract | Cited by 2 | PDF Full-text (175 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
Select/unselect all
Displaying article 1-5
Select articles Export citation of selected articles as:

Last update: 4 March 2014

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert